Notice to readers regarding the retraction note included in this issue.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Works matching IS 00218820 AND DT 2022 AND VI 75 AND IP 2
Results: 13
1
2
Determining the absolute configuration of vanitaracin A, an anti-hepatitis B virus agent.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 92, doi. 10.1038/s41429-021-00496-1
- By:
- Publication type:
- Article
3
New antioxidants from the culture broth of Coprinopsis echinospora.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 113, doi. 10.1038/s41429-021-00495-2
- By:
- Publication type:
- Article
4
Nigirpexin E, a new azaphilone derivative with anti-tobacco mosaic virus activity from soil-derived fungus Trichoderma afroharzianum LTR-2.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 117, doi. 10.1038/s41429-021-00485-4
- By:
- Publication type:
- Article
5
Kimidinomycin, a new antibiotic against Mycobacterium avium complex, produced by Streptomyces sp. KKTA-0263.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 72, doi. 10.1038/s41429-021-00494-3
- By:
- Publication type:
- Article
6
Isolation of new derivatives of the 20-membered macrodiolide bispolide from Kitasatospora sp. MG372-hF19.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 77, doi. 10.1038/s41429-021-00492-5
- By:
- Publication type:
- Article
7
The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 60, doi. 10.1038/s41429-021-00491-6
- By:
- Publication type:
- Article
8
Rausuquinone, a non-glycosylated pluramycin-class antibiotic from Rhodococcus.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 86, doi. 10.1038/s41429-021-00489-0
- By:
- Publication type:
- Article
9
TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 98, doi. 10.1038/s41429-021-00486-3
- By:
- Publication type:
- Article
10
Yeppoonic acids A – D: 1,2,4-trisubstituted arene carboxylic acid co-metabolites of conglobatin from an Australian Streptomyces sp.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 108, doi. 10.1038/s41429-021-00493-4
- By:
- Publication type:
- Article
11
Corrections to: Multiple articles in the Journal of Antibiotics.
- Published in:
- 2022
- Publication type:
- Correction Notice
12
Correction: Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
13
RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article.
- Published in:
- Journal of Antibiotics, 2022, v. 75, n. 2, p. 122, doi. 10.1038/s41429-021-00430-5
- By:
- Publication type:
- Article